Clinical Trials Directory

Trials / Sponsors / Ever Neuro Pharma GmbH

Ever Neuro Pharma GmbH

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingCERebrolysin In CADASIL
Cadasil
Phase 22023-11-29
TerminatedIMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE
Chronic Stroke, Subacute Stroke
Phase 22021-06-25
CompletedCerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness
Acute Ischemic Stroke
—2018-04-24
TerminatedCerebrolysin REGistry Study in Stroke
Ischemic Stroke
—2014-05-01
TerminatedThe CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery
Traumatic Brain Injury
Phase 42013-09-01
CompletedA Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
Vascular Dementia
Phase 42006-10-01
CompletedThe Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
Ischemic Stroke
Phase 42006-09-01
CompletedCombined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
Stroke
Phase 32005-10-01
CompletedComparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease
Alzheimer Disease
Phase 22004-10-01
WithdrawnCerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Alzheimer Disease
Phase 4—